GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (LTS:0KCS) » Definitions » Cyclically Adjusted PS Ratio

OPKO Health (LTS:0KCS) Cyclically Adjusted PS Ratio : 0.62 (As of May. 25, 2025)


View and export this data going back to 2018. Start your Free Trial

What is OPKO Health Cyclically Adjusted PS Ratio?

As of today (2025-05-25), OPKO Health's current share price is $1.2601. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $2.03. OPKO Health's Cyclically Adjusted PS Ratio for today is 0.62.

The historical rank and industry rank for OPKO Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0KCS' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.48   Med: 2.97   Max: 117.87
Current: 0.62

During the past years, OPKO Health's highest Cyclically Adjusted PS Ratio was 117.87. The lowest was 0.48. And the median was 2.97.

LTS:0KCS's Cyclically Adjusted PS Ratio is ranked better than
83.33% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.055 vs LTS:0KCS: 0.62

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.223. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $2.03 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


OPKO Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted PS Ratio Chart

OPKO Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.43 3.21 0.73 0.81 0.74

OPKO Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.64 0.76 0.74 0.82

Competitive Comparison of OPKO Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.


;
;

OPKO Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

OPKO Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.2601/2.03
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.223/134.9266*134.9266
=0.223

Current CPI (Mar. 2025) = 134.9266.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.092 100.684 0.123
201509 0.277 100.392 0.372
201512 0.509 99.792 0.688
201603 0.533 100.470 0.716
201606 0.641 101.688 0.851
201609 0.540 101.861 0.715
201612 0.297 101.863 0.393
201703 0.477 102.862 0.626
201706 0.519 103.349 0.678
201709 0.440 104.136 0.570
201712 0.288 104.011 0.374
201803 0.456 105.290 0.584
201806 0.471 106.317 0.598
201809 0.446 106.507 0.565
201812 0.387 105.998 0.493
201903 0.379 107.251 0.477
201906 0.386 108.070 0.482
201909 0.390 108.329 0.486
201912 0.360 108.420 0.448
202003 0.330 108.902 0.409
202006 0.470 108.767 0.583
202009 0.668 109.815 0.821
202012 0.772 109.897 0.948
202103 0.851 111.754 1.027
202106 0.684 114.631 0.805
202109 0.592 115.734 0.690
202112 0.615 117.630 0.705
202203 0.499 121.301 0.555
202206 0.435 125.017 0.469
202209 0.240 125.227 0.259
202212 0.247 125.222 0.266
202303 0.316 127.348 0.335
202306 0.353 128.729 0.370
202309 0.238 129.860 0.247
202312 0.242 129.419 0.252
202403 0.246 131.776 0.252
202406 0.261 132.554 0.266
202409 0.174 133.029 0.176
202412 0.271 133.157 0.275
202503 0.223 134.927 0.223

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OPKO Health  (LTS:0KCS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


OPKO Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

OPKO Health Headlines

No Headlines